#testing certifications

Is simply complying with regulations sufficient to secure the pharmaceutical supply chains of today?

Previously, supplier compliance was a minimum requirement for most pharmaceutical companies. The primary aim was to get through audits without being penalized. Eventually, this method turned out to be risky. Problems like supply disruptions, quality failures, and ethical issues revealed the vulnerabilities of global supply networks.

Changing expectations prompted companies to invest in long-term stability and accountability. This transformation brought to light the issue of pharmaceutical supply chain resilience. Resilience is not only about dealing with the problems but also about creating systems that stop them from happening, keep patients safe, and guarantee the uninterrupted supply of medicines.

One of the frameworks that facilitates this transition is the Pharmaceutical Supply Chain Initiative, or PSCI. PSCI is designed to help companies to not only remain compliant but also to establish supply chains that are ethical, strong, and ready for audits.

Why Supply Chain Risk Is Rising

The supply chains of pharmaceuticals have become increasingly complicated. They consist of worldwide sourcing, contract manufacturing, and several layers of suppliers. The complexity not only brings along risks but also makes the situations less visible on the ground.

A forecast for the industry in 2025 indicated that more than 65% of world production of active pharmaceutical ingredients would be in Asia, thus raising the risk of supply disruption and quality concerns.

This high concentration implies that a single disruption can have a domino effect on numerous companies simultaneously. Moreover, it strengthens the demand for companies to present their sourcing as responsible and their supplier monitoring as firm.

What PSCI Brings to the Pharma Industry

The Pharmaceutical Supply Chain Initiative (PSCI) is an initiative launched by pharmaceutical companies to foster responsible practices within the supply chain globally. It gives principles covering ethics, labor rights, health and safety, environment, and management systems that are common to all.

By not acting alone, the companies that are members of the initiative interact and disclose their audit results. This practice helps to avoid performing the same audits multiple times and makes it easier for the suppliers to concentrate on real progress instead of going through the same inspections again and again.

The PSCI is also an advocate of ongoing improvement. The suppliers are encouraged to make the systems stronger rather than just addressing the individual problems. This methodology helps the longevity of compliance and stability.

Applying PSCI Best Practices

Implementing PSCI best practices brings about the transformation of a company's supply chain into a more robust and trustworthy one. The main elements of these practices are prevention, transparency, and accountability.

The risk of ethical violations is significantly lowered due to well-defined moral standards. Worker safety, as well as the safety of the facilities, is assured by the establishment of robust safety systems. Operations are made to be sustainable by the utilization of environmental controls. The combination of these practices results in fewer disruptions and greater trust.

Supplier onboarding and monitoring that incorporate PSCI principles provide companies with better risk and performance control.

Building a Strong Pharma Quality Culture

A reliable supply chain is not solely dependent on regulations. A common perspective emphasizing quality and accountability is what it finally boils down to. This is the reason why the pharmaceutical quality culture comes into play as an important factor.

A quality culture is a situation in which everyone, no matter the rank, is aware of his/her contribution towards upholding the product integrity and the safety of the patients. It supports the prompt disclosure of problems and lifetime education.

Those suppliers who practice a strong quality culture are also the ones who are subjected to simpler audits. Besides, they are the ones who take less time to bounce back from the disruptions and to keep their performance level steady.

Strengthening Supplier Relationships

The effective management of supplier relationships in the pharmaceutical sector is not restricted to contracts and audits. Rather, it is founded on trust, good communication, and common objectives. 

Moreover, suppliers can be encouraged to invest in better systems through the preparation of joint improvement plans. In addition, the support provided through open dialogue leads to the quick resolution of issues.

Building strong supplier relationships results in supply chains that are more flexible and resilient during stressful periods.

Becoming Audit-Ready Through PSCI

Audit readiness is now a compulsory norm. Regulators, along with the customers, want proof of responsible sourcing and risk management.

PSCI-conforming audits are the solution for companies to get ready for this situation. Common audits lessen the load and at the same time keep the quality uniform. In addition, they put an emphasis on management systems rather than one-off corrections.

This strategy is in favor of long-term compliance and earns the trust of stakeholders.

Conclusion

The drug industry must not count on compliance only anymore. It is the right behavior, quality systems and continuity of supply that have become the main factors for business success and patient safety.